+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Ceragon Networks Ltd (CRNT) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 45 Pages
  • June 2026
  • GlobalData
  • ID: 4435443
Ceragon Networks Ltd (CRNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ceragon Networks Ltd (Ceragon) is a provider of wireless backhaul solutions. The company offers wireless transport solutions and services, that enable cellular operators, service providers, and private networks in build new networks and transition existing ones towards 4G and 5G services. It also offers a wide range of services, including voice, machine-to-machine (M2M), mobile and fixed broadband, Internet of Things (IoT) connectivity, public safety, and other mission-critical services under the Fiber and Ceragon brand names. The company also offers advisory and planning, deployment, operations and managed services, maintenance, and training services. Ceragon serves various sectors, such as internet service providers, utilities, public safety, oil and gas offshore drilling platforms, and maritime communications. The company markets solutions through direct sales, OEMs, resellers, distributors, and system integrators. The company has a business presence across Asia-Pacific, Europe, the Middle East, Africa and the Americas. Ceragon is headquartered in Rosh Ha’Ayin, Israel.

Ceragon Networks Ltd Key Recent Developments

  • Nov 11, 2025: Ceragon Reports Third Quarter Financial Results for 2025
  • Aug 06, 2025: Ceragon Reports 2025 Second Quarter Financial Results
  • May 07, 2025: Ceragon Networks Reports 2025 First Quarter Financial Results
  • Feb 11, 2025: Ceragon Reports 18.3% Increase in Quarterly Revenue GAAP EPS of $0.04 Per Share in the Fourth Quarter

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Jazz Pharmaceuticals Plc - Key Facts
  • Jazz Pharmaceuticals Plc - Key Employees
  • Jazz Pharmaceuticals Plc - Key Employee Biographies
  • Jazz Pharmaceuticals Plc - Major Products and Services
  • Jazz Pharmaceuticals Plc - History
  • Jazz Pharmaceuticals Plc - Company Statement
  • Jazz Pharmaceuticals Plc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Jazz Pharmaceuticals Plc - Business Description
  • Geographical Segment: All Other
  • Performance
  • Geographical Segment: Europe
  • Performance
  • Geographical Segment: United States
  • Performance
  • R&D Overview
  • Jazz Pharmaceuticals Plc - Corporate Strategy
  • Jazz Pharmaceuticals Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Jazz Pharmaceuticals Plc - Strengths
  • Jazz Pharmaceuticals Plc - Weaknesses
  • Jazz Pharmaceuticals Plc - Opportunities
  • Jazz Pharmaceuticals Plc - Threats
  • Jazz Pharmaceuticals Plc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Jazz Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Jazz Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Jazz Pharmaceuticals Plc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jun 18, 2026: Jazz and AbCellera sign deal for T-cell engagers in solid tumours
  • May 05, 2026: Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results
  • Apr 21, 2026: Jazz Pharmaceuticals to Report First Quarter Financial Results on May 5, 2026
  • Mar 18, 2026: Zymeworks Presents Ziihera (zanidatamab-hrii) Data at 2026 AACR Annual Meeting
  • Mar 18, 2026: Jazz Pharmaceuticals to Present Clinical and Preclinical Oncology Data at AACR 2026
  • Mar 02, 2026: Zymeworks and Royalty Pharma Enter Into $250 Million Royalty-Backed Note Financing
  • Feb 24, 2026: Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance
  • Feb 17, 2026: Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
  • Feb 17, 2026: Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences
  • Feb 02, 2026: ALX Oncology announces Phase Ib/II trial results for breast cancer
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Jazz Pharmaceuticals Plc, Key Facts
  • Jazz Pharmaceuticals Plc, Key Employees
  • Jazz Pharmaceuticals Plc, Key Employee Biographies
  • Jazz Pharmaceuticals Plc, Major Products and Services
  • Jazz Pharmaceuticals Plc, History
  • Jazz Pharmaceuticals Plc, Other Locations
  • Jazz Pharmaceuticals Plc, Subsidiaries
  • Jazz Pharmaceuticals Plc, Key Competitors
  • Jazz Pharmaceuticals Plc, Ratios based on current share price
  • Jazz Pharmaceuticals Plc, Annual Ratios
  • Jazz Pharmaceuticals Plc, Interim Ratios
  • Jazz Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Jazz Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Jazz Pharmaceuticals Plc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Jazz Pharmaceuticals Plc, Performance Chart (2021 - 2025)
  • Jazz Pharmaceuticals Plc, Ratio Charts
  • Jazz Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Jazz Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026